Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
about
Lung cancer and chronic obstructive pulmonary disease: From a clinical perspectiveMicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis.Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2microRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells.Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer.
P2860
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lovastatin lactone elicits hum ...... COX-2/PPARγ-dependent pathway.
@en
type
label
Lovastatin lactone elicits hum ...... COX-2/PPARγ-dependent pathway.
@en
prefLabel
Lovastatin lactone elicits hum ...... COX-2/PPARγ-dependent pathway.
@en
P2093
P2860
P356
P1433
P1476
Lovastatin lactone elicits hum ...... COX-2/PPARγ-dependent pathway.
@en
P2093
Burkhard Hinz
Kristin Emmrich
Nadine Mittag
Robert Ramer
Udo Walther
P2860
P304
10345-10362
P356
10.18632/ONCOTARGET.7213
P407
P577
2016-02-05T00:00:00Z